Skip to contentI
INSMED Inc
I
INSMINSMED Inc Q1 2021 · 10-Q
Revenue$40.21M$40.21M+9.1% vs Q1 2020 Net Income-$91.64M-$91.64MN/M vs Q1 2020 EPS Diluted-$0.89-$0.89N/M vs Q1 2020 Operating Income-$83,833,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
Free Cash Flowderived-$129,462,000N/M Margins · derivedOperating margin-208.5%−44.7 pt vs Q1 2020
Net margin-227.9%−47.8 pt vs Q1 2020
ended Mar 31, 2021 · filed May 6, 2021 · 36 d after period end